NAMS
NewAmsterdam Pharma Company N.V.$19.85-0.24 (-1.20%)Prev Close$20.06·MCap$2.30B·P/E—·Vol1.07M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
3
$2.67M
◆
Net Activity
Net Seller
$2.67M
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at NewAmsterdam Pharma Company N.V. (NAMS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 3 insider sales totaling $2.67M. The most recent insider transaction was by Kooij Louise Frederika (Chief Accounting Officer), who sold $2.42M worth of shares on Jan 23, 2026. NewAmsterdam Pharma Company N.V. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.30B.
NAMS Insider Trading Activity
NAMS Insider Buying Activity
The following table shows recent insider purchases of NewAmsterdam Pharma Company N.V. (NAMS) stock reported via SEC Form 4 filings.
NAMS Insider Selling Activity
The following table shows recent insider sales of NewAmsterdam Pharma Company N.V. (NAMS) stock reported via SEC Form 4 filings.